Skip to main content

Fatal Complications of Epidermolysis Bullosa: Awareness Campaign Announced

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

No Baby Blisters has announced an awareness campaign highlighting fatal complications of epidermolysis bullosa in infants. The charity provides specialized wound care, pain medications, and nutritional support to over 5,100 children globally.

-- No Baby Blisters has introduced a targeted awareness campaign focused on the life-threatening complications of epidermolysis bullosa (EB) in infants. The campaign seeks to shine a light on the urgent and often invisible struggles faced by families of children living with EB.

More details can be found at https://nobabyblisters.org/#1

This announcement comes at a time when awareness of rare pediatric genetic disorders remains critically low. Epidermolysis bullosa is a rare genetic disorder that causes fragile skin and severe blistering, affecting an estimated 500,000 people worldwide. In severe forms, particularly junctional EB, the cumulative mortality risk reaches 40 to 44.7 percent by age one, according to the National Library of Medicine, while the Herlitz subtype carries a 61.8 percent mortality risk by age 15.

Despite the devastating severity of these statistics, public awareness of EB remains alarmingly limited, with many medical professionals, policymakers, and potential donors having little to no knowledge of the condition and the profound toll it takes on affected infants and their families. No Baby Blisters has launched their latest campaign to directly address this gap, stepping forward to ensure that EB is no longer an invisible crisis and that the families navigating it have access to the support, resources, and visibility they urgently deserve.

"Epidermolysis bullosa robs infants of the most basic comfort: being held, being touched, being cared for without pain," says a representative of No Baby Blisters. "Our goal is to make sure no family faces that reality without support, and that the broader public understands just how serious and how neglected this condition truly is."

No Baby Blisters is a charity providing direct support to medically neglected children with EB and craniofacial cancers. It was founded by Aaron Tabor, MD, an NIH-funded skin researcher who identified a critical and largely unaddressed gap in care for children suffering from EB globally. The organization holds 501(c)(3) nonprofit status and carries a Platinum GuideStar transparency rating.

Families supported by the charity's Hero Guardian Angel Program receive access to specialized wound bandages, severe pain medications, nutrition, blood transfusions, hospitalization, antibiotics, and IVs. No Baby Blisters has supported more than 5,100 children across five continents, demonstrating both the scale of need and the impact of targeted intervention.

"Every donation matters, whether $1 or $1,000, and it is those everyday acts of generosity that keep these children alive," says the spokesperson for No Baby Blisters.

Those who wish to support the campaign or contribute to the charity may visit www.nobabyblisters.org/donate

Contact Info:
Name: Aaron Tabor
Email: Send Email
Organization: No Baby Blisters
Address: 731 Chapel Hills Drive , Colorado Springs, Colorado 80920, United States
Website: https://nobabyblisters.org/

Source: PressCable

Release ID: 89191504

Should any problems, inaccuracies, or doubts arise from the content contained within this press release, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is at the core of our commitment to our readers.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  265.82
-3.17 (-1.18%)
AAPL  294.80
+2.12 (0.72%)
AMD  448.29
-10.50 (-2.29%)
BAC  50.78
+0.23 (0.45%)
GOOG  383.82
-2.95 (-0.76%)
META  603.00
+4.14 (0.69%)
MSFT  407.77
-4.89 (-1.18%)
NVDA  220.78
+1.34 (0.61%)
ORCL  186.83
-7.01 (-3.62%)
TSLA  433.45
-11.55 (-2.60%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.